hit counter

3 New Narcolepsy Medications (2015) In Clinical Trials

Narcolepsy is a neurological disorder associated with the brain’s inability to regulate sleep-wake cycles (and the circadian rhythm).  As a result, individuals diagnosed with narcolepsy often experience excessive daytime sleepiness and may fall asleep unexpectedly.  Some have suggested that the excessive daytime sleepiness stemming from narcolepsy is akin to how a normal person feels if …

Read more

3 New Bipolar Medications (2015): Drugs In Clinical Trials

Bipolar disorder is a condition characterized by cyclical mood swings, transitioning from depression to mania (or hypomania).  For a period of time, an individual with bipolar disorder will experience debilitating bouts of depression – and often unexpectedly, their entire neurophysiology will shift to facilitate a state of mania (elevated mood).  Diagnostically, there are multiple types …

Read more

14 New ADHD Medications In the Pipeline (2015)

ADHD (attention-deficit/hyperactivity disorder) is a condition characterized by inability to concentrate and often comorbid hyperactive behaviors.  It is considered the most common psychiatric disorder among children and adolescents (affecting approximately 5%) and is fairly common among adults (affecting approximately 4%).  Individuals with ADHD may face serious difficulties completing projects, studying at school, holding a steady …

Read more

20 New Antidepressants In The Pipeline (2015): Drugs In Clinical Trials

For individuals in the United States between the age of 15 and 44, major depression is the leading cause of disability.  Major depression is often a heritable condition, caused by maladaptive genes getting transferred across generations.  That said, not everyone diagnosed with major depressive disorder inherited the condition from ancestors or should be blaming their …

Read more

20+ New Schizophrenia Medications In Development (2015)

It is estimated that over 2.5 million adults in the United States have been diagnosed with schizophrenia; this equates to approximately 1.1% of the population.  There are many different types of schizophrenia, in fact, genetic clusters suggest it is 8 distinct diseases.  Therefore not everyone diagnosed with schizophrenia has the same set of symptoms. Certain …

Read more

TMS For Anxiety Disorders (Transcranial Magnetic Stimulation)

TMS (Transcranial magnetic stimulation) is considered a non-invasive neurostimulation procedure aimed at normalizing brain activity among those with abnormal neurological function.  Individuals diagnosed with psychiatric conditions (e.g. depression) may turn to TMS for relief if standard first-line pharmacological options fail to ameliorate symptoms.  A TMS device works by using pulsed magnetic fields to generate low-grade electrical currents. …

Read more